Browse the evidence

Insulin acts as a rapid, minute-to-minute indicator of energy balance that tracks acute metabolic changes better than leptin, which reflects stable total fat mass.

Don't expect your body's fat-regulating hormones to react to every single meal instantly. Leptin changes slowly as you gain/lose fat. Insulin reacts quickly to meals but is designed to manage glucose, not just signal fullness. Focus on long-term trends, not daily hormonal spikes.

Standardized exercise training produces highly variable cardiorespiratory fitness (CRF) responses in humans, with a significant portion of individuals showing no improvement (non-responders) despite adherence to prescribed protocols.

If you exercise consistently but see no change in your fitness tests, you are likely a 'non-responder' to that specific dose. This is common and often genetic. Do not stop exercising, as other health benefits likely persist. Consider adjusting the type, intensity, or duration of exercise to find a protocol that works for your biology.

Ingestion of a mixed meal containing glucose completely suppresses hepatic glucose output within 30 minutes in healthy humans.

When you eat a normal mixed meal, your liver stops releasing glucose into your bloodstream within 30 minutes. This is a normal, healthy physiological response driven by insulin. You do not need to worry about your liver continuing to produce glucose while you are digesting food; your body handles this transition automatically.

Approximately 19% of the carbohydrate content from a mixed meal is stored as liver glycogen in healthy humans, with net synthesis continuing for up to 4 hours post-meal.

Your liver stores about 28 grams of glycogen from a typical mixed meal, which is about 19% of the carbs you ate. This storage process takes up to 4 hours. This is a normal, healthy storage mechanism, not fat gain.

The health benefits attributed to ellagitannin-rich foods (pomegranates, walnuts) are primarily driven by Urolithin A, but these benefits are conditional on the individual's gut microbiota composition (metabotype).

Eating pomegranates or walnuts is healthy, but your gut bacteria must convert them into Urolithin A for maximum benefit. If you are a 'non-producer' (UM-0), you might not get these specific benefits. Testing your metabotype or using Uro-A supplements can ensure you get the intended effects.

Abdominal (visceral) obesity is the primary initiator of metabolic syndrome, driving insulin resistance and multi-organ metabolic derangements through elevated free fatty acids, reduced adiponectin, and leptin resistance.

Focus on reducing visceral fat through lifestyle changes rather than just total weight loss. Regular physical activity and dietary adherence (e.g., Mediterranean diet) are key interventions to offset insulin resistance and reduce the risk of metabolic syndrome, regardless of total BMI.

Insulin resistance is the essential common denominator of metabolic syndrome, driven by intracellular lipid accumulation (FFA, diacylglycerol) which interferes with insulin signaling pathways (IRS-1 phosphorylation).

Improving insulin sensitivity through exercise and diet can break the cycle of metabolic syndrome. Exercise stimulates skeletal muscle oxidative enzymes and mitochondrial biogenesis, directly counteracting the insulin resistance caused by intracellular lipid accumulation.

Tirzepatide does not increase the risk of hypoglycemia compared to placebo and has a lower risk compared to basal insulin.

Unlike insulin, Tirzepatide does not increase the risk of low blood sugar (hypoglycemia) when used alone. In fact, it has a lower risk of causing hypoglycemia compared to basal insulin. This makes it a safer option for patients who are concerned about blood sugar lows.

Reduced HRV is a consistent predictor of various diseases, including diabetes, cardiovascular disease, obesity, and psychiatric disorders, and is associated with inflammation and insulin resistance.

Monitor your HRV as a general indicator of your health status. Consistently low HRV may be a sign of underlying issues such as inflammation, insulin resistance, or stress. While not a diagnostic tool on its own, it can help identify individuals at risk for cardiovascular, metabolic, and psychiatric conditions, prompting earlier lifestyle interventions or medical consultation.

Fermentation of dietary fibers by gut bacteria produces short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate, which reduce inflammation, provide energy to colon cells, and regulate metabolism.

Eat fiber-rich foods to feed your gut bacteria, which will produce beneficial short-chain fatty acids that reduce gut inflammation and support colon health.

SGLT2 inhibitors and GLP-1 receptor agonists provide cardiovascular benefits (reduced MACE and heart failure hospitalization) and slow kidney disease progression, distinct from older glucose-lowering drugs.

If you have Type 2 Diabetes and heart or kidney issues, ask your doctor about SGLT2 inhibitors (like Jardiance, Farxiga) or GLP-1 agonists (like Ozempic, Trulicity). These drugs protect your heart and kidneys beyond just lowering sugar, unlike older diabetes medications.

Sleep restriction (4-5 hours per night) causes hormonal changes characterized by decreased leptin and increased ghrelin, leading to increased hunger, appetite, and a preference for high-carbohydrate and high-fat foods.

If you are sleep-deprived, your body is biologically wired to make you hungrier and crave carbs and fats. Recognize this as a hormonal response, not a personal failure. Prioritize sleep to regulate these hormones naturally.

Obesity is primarily driven by behavioral and environmental factors (sedentary lifestyle and excess energy intake) interacting with genetic susceptibility, rather than genetics alone.

Focus on your environment and habits, not just your genes. Reduce sedentary time and manage calorie intake, as these are the primary levers for weight change.

Bariatric surgery resolves obesity-associated gonadal dysfunction (PCOS in women, MOSH in men) in the vast majority of severely obese patients, with resolution rates of 96% for PCOS and 87% for MOSH.

If you are severely obese and have been diagnosed with PCOS or Male Obesity-Associated Secondary Hypogonadism (MOSH), bariatric surgery is the most effective treatment for resolving these conditions. Unlike diet or medication which often only manage symptoms, surgery addresses the underlying metabolic drivers, leading to resolution in nearly all women with PCOS and most men with MOSH. Consult a bariatric specialist to see if you are a candidate.

Bariatric surgery reverses the sex-specific hormonal imbalances caused by obesity: it increases testosterone in men and decreases testosterone in women, while increasing SHBG and decreasing estradiol in both.

Bariatric surgery normalizes sex hormones in a sex-specific way. Men typically see their testosterone levels rise to normal ranges, while women see their elevated testosterone levels drop. Both groups see an increase in Sex Hormone Binding Globulin (SHBG) and a decrease in Estradiol. This hormonal normalization is key to resolving fertility and sexual health issues associated with obesity.

Obesity-associated gonadal dysfunction is highly prevalent in severely obese patients, affecting 36% of women (PCOS) and 64% of men (MOSH).

If you are severely obese, you are at high risk for hormonal reproductive issues. About 1 in 3 severely obese women has PCOS, and nearly 2 in 3 severely obese men has low testosterone (MOSH). Screening for these conditions is recommended during initial diagnostic workup for severe obesity.

Gait speed is a critical predictor of survival, disability, and mobility loss in older adults, with a speed of approximately 0.8 m/s indicating median life expectancy.

Monitor your walking speed. If you walk slower than 0.8 meters per second (roughly 1.8 mph), you are at higher risk for early mortality and disability. Use this as a signal to engage in regular physical activity, particularly strength and balance training, to preserve your mobility and longevity.

Bariatric surgery reduces overall mortality by 25–50% in the long term and is the most effective treatment for morbid obesity.

If you have severe obesity (BMI >40, or >35 with health issues), bariatric surgery is the most effective medical intervention available. It doesn't just help you lose weight; it significantly reduces your risk of dying from obesity-related causes like heart disease and diabetes. Consult a specialist to see if you qualify.

Muscle disuse leads to a decline in basal muscle protein synthesis and, in the early stages (<5 days), a transient increase in muscle protein breakdown, resulting in net muscle loss.

Understand that muscle loss starts immediately upon disuse. The body stops building muscle (synthesis drops) and may break it down faster for the first few days. This is why rapid intervention with nutrition (protein) and eventual retraining is critical to minimize permanent loss.

Higher muscle strength (specifically grip and knee extension) in young adulthood is independently associated with a lower incidence of coronary heart disease and stroke later in life, even after adjusting for body mass index, blood pressure, and socioeconomic status.

Prioritize building functional muscle strength, particularly grip and leg strength, as a long-term strategy for heart health. This benefit is independent of your body weight. Incorporate resistance training into your routine to reduce your risk of coronary heart disease and stroke later in life.

Being underweight in young adulthood is associated with an increased risk of intracerebral and subarachoid hemorrhage (stroke types), whereas obesity is associated with increased risk of coronary heart disease and intracerebral infarction.

Maintain a healthy body weight range. While obesity is a known risk for heart disease and ischemic stroke, being underweight in young adulthood is also a risk factor for hemorrhagic stroke. Aim for a balanced weight rather than extreme leanness.

Physiologic testosterone replacement (300 mcg/day transdermal patch) significantly increases bone mineral density at the hip and radius, fat-free mass, and thigh muscle cross-sectional area in women with hypopituitarism-induced androgen deficiency.

For women with hypopituitarism and low testosterone, a physiologic dose of transdermal testosterone (300 mcg/day) improves bone density at the hip and radius, increases muscle mass, and improves mood and sexual function without increasing body fat. This treatment is well-tolerated, though mild skin irritation is common. It does not significantly improve spine bone density.

Physiologic testosterone replacement improves mood and sexual function (libido, arousal, behavior/experience) in women with hypopituitarism.

For women with hypopituitarism and low testosterone, physiologic testosterone replacement improves mood, reduces depression, and enhances sexual function (libido, arousal, and sexual experience). These benefits occur without significant changes in cognitive function or body fat.

Plasma ghrelin levels increase with fasting and decrease after meals, with levels being higher after diet-induced weight loss compared to gastric bypass surgery.

When you lose weight through dieting, your body naturally increases ghrelin levels, making you hungrier. This is a biological response, not a personal failure. Gastric bypass surgery, by contrast, suppresses ghrelin levels, which may contribute to its effectiveness. Managing expectations about increased hunger during weight loss can help in adhering to long-term strategies.